Commercialization And Logistics

31. Perfusion: Planning A Run 6/16/2025

    Learn about a logical approach for defining the operation of a perfusion run. We will break down the process using the three following steps: knowledge space, design space, and control space.

32. Auto, Allo, And AI 8/18/2023

    CTO experts debate autologous and allogeneic, and how automation improves the CAR-T cell process every step from collection to infusion. They also discuss the major ways AI optimizes automation.

33. Supply Chain Efficiency And Sourcing In Gene Therapy 11/4/2025

    An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

34. Uninstalling CTS Dynacellect Bead Removal Kit 6/9/2025

    A detailed walkthrough on how to uninstall the Gibco CTS DynaCellect Bead Removal Kit when the bead removal protocol or the Gibco CTS DynaCellect magnetic separation system is completed.

35. Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities 11/2/2018

    Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.

36. Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology 5/6/2024

    During this segment, Nguyen and Wagner agree that scalability will be a top concern for most CGT companies.

37. CTS DynaCellect Fluidics Demonstration 6/9/2025

    Streamline and customize your cell processing workflow with automated, precise control over fluid movement and transfer parameters.

38. Master The 2-Point Calibration Process To Maintain Data Integrity 5/19/2025

    Ensure accurate sensor readings with an innovative software by mastering the 2-point calibration process. Learn more about how and why regular calibration supports data integrity and compliance.

39. Supporting Efficacy And Scaling With A Next-Generation T Cell AOF Formulation Medium 6/16/2025

    Explore a novel, next-generation medium designed with an animal component-free formulation to boost therapeutic potential and enable reproducible T cells.

40. Scaling Viral Vectors 11/13/2023

    Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.